nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—ABCB1—Topotecan—cervical cancer	0.106	0.625	CbGbCtD
Imipramine—CHRM3—ureter—cervical cancer	0.0775	0.131	CbGeAlD
Imipramine—CYP3A4—Topotecan—cervical cancer	0.0636	0.375	CbGbCtD
Imipramine—KCND2—decidua—cervical cancer	0.0173	0.0291	CbGeAlD
Imipramine—KCND3—uterine cervix—cervical cancer	0.0158	0.0266	CbGeAlD
Imipramine—CHRM3—exocrine gland—cervical cancer	0.0153	0.0257	CbGeAlD
Imipramine—CYP2C18—uterine cervix—cervical cancer	0.0144	0.0243	CbGeAlD
Imipramine—KCND3—uterus—cervical cancer	0.0132	0.0222	CbGeAlD
Imipramine—CYP2C18—mammalian vulva—cervical cancer	0.0126	0.0212	CbGeAlD
Imipramine—KCND2—female gonad—cervical cancer	0.0124	0.0208	CbGeAlD
Imipramine—CHRM5—epithelium—cervical cancer	0.0119	0.02	CbGeAlD
Imipramine—ADRA1D—epithelium—cervical cancer	0.0106	0.0179	CbGeAlD
Imipramine—SLC22A2—renal system—cervical cancer	0.0105	0.0177	CbGeAlD
Imipramine—ADRA1B—renal system—cervical cancer	0.0101	0.017	CbGeAlD
Imipramine—CYP2C18—vagina—cervical cancer	0.00976	0.0164	CbGeAlD
Imipramine—SLC22A4—decidua—cervical cancer	0.00795	0.0134	CbGeAlD
Imipramine—ADRA1D—female reproductive system—cervical cancer	0.00789	0.0133	CbGeAlD
Imipramine—ORM1—endometrium—cervical cancer	0.00785	0.0132	CbGeAlD
Imipramine—SLC22A4—renal system—cervical cancer	0.00781	0.0131	CbGeAlD
Imipramine—SLC22A3—uterine cervix—cervical cancer	0.00759	0.0128	CbGeAlD
Imipramine—SLC22A4—endometrium—cervical cancer	0.00755	0.0127	CbGeAlD
Imipramine—SLC22A1—renal system—cervical cancer	0.00743	0.0125	CbGeAlD
Imipramine—SLC22A3—renal system—cervical cancer	0.00711	0.012	CbGeAlD
Imipramine—KCND3—lymph node—cervical cancer	0.00694	0.0117	CbGeAlD
Imipramine—SLC22A3—endometrium—cervical cancer	0.00687	0.0116	CbGeAlD
Imipramine—SLC22A3—mammalian vulva—cervical cancer	0.00664	0.0112	CbGeAlD
Imipramine—ORM1—female reproductive system—cervical cancer	0.0065	0.0109	CbGeAlD
Imipramine—HTR7—epithelium—cervical cancer	0.00633	0.0107	CbGeAlD
Imipramine—SLC22A4—female reproductive system—cervical cancer	0.00625	0.0105	CbGeAlD
Imipramine—SLC6A2—decidua—cervical cancer	0.0062	0.0104	CbGeAlD
Imipramine—CHRM3—renal system—cervical cancer	0.00617	0.0104	CbGeAlD
Imipramine—HTR1A—renal system—cervical cancer	0.00614	0.0103	CbGeAlD
Imipramine—ADRA1A—epithelium—cervical cancer	0.0061	0.0103	CbGeAlD
Imipramine—HTR7—renal system—cervical cancer	0.00587	0.00988	CbGeAlD
Imipramine—KCNH2—uterine cervix—cervical cancer	0.00584	0.00984	CbGeAlD
Imipramine—HTR2C—female reproductive system—cervical cancer	0.00584	0.00984	CbGeAlD
Imipramine—SLC22A3—female reproductive system—cervical cancer	0.00569	0.00958	CbGeAlD
Imipramine—ADRA1A—renal system—cervical cancer	0.00566	0.00953	CbGeAlD
Imipramine—SLC22A4—vagina—cervical cancer	0.00565	0.00952	CbGeAlD
Imipramine—SLC6A4—female reproductive system—cervical cancer	0.00554	0.00932	CbGeAlD
Imipramine—CHRM1—female reproductive system—cervical cancer	0.00552	0.00929	CbGeAlD
Imipramine—KCNH2—renal system—cervical cancer	0.00547	0.0092	CbGeAlD
Imipramine—SLC22A1—vagina—cervical cancer	0.00538	0.00907	CbGeAlD
Imipramine—KCNH2—endometrium—cervical cancer	0.00529	0.0089	CbGeAlD
Imipramine—SLC22A3—female gonad—cervical cancer	0.00518	0.00872	CbGeAlD
Imipramine—SLC22A3—vagina—cervical cancer	0.00515	0.00866	CbGeAlD
Imipramine—CHRM3—female reproductive system—cervical cancer	0.00494	0.00831	CbGeAlD
Imipramine—SLC6A2—female reproductive system—cervical cancer	0.00488	0.00821	CbGeAlD
Imipramine—KCNH2—uterus—cervical cancer	0.00487	0.0082	CbGeAlD
Imipramine—HRH1—epithelium—cervical cancer	0.00472	0.00795	CbGeAlD
Imipramine—HTR7—female reproductive system—cervical cancer	0.0047	0.00791	CbGeAlD
Imipramine—HRH1—uterine cervix—cervical cancer	0.00468	0.00789	CbGeAlD
Imipramine—CYP1A2—renal system—cervical cancer	0.00468	0.00788	CbGeAlD
Imipramine—CHRM3—female gonad—cervical cancer	0.00449	0.00756	CbGeAlD
Imipramine—CYP2B6—renal system—cervical cancer	0.00449	0.00755	CbGeAlD
Imipramine—HRH1—decidua—cervical cancer	0.00446	0.00751	CbGeAlD
Imipramine—Benazepril—MTHFR—cervical cancer	0.00439	1	CrCbGaD
Imipramine—KCNH2—female reproductive system—cervical cancer	0.00438	0.00737	CbGeAlD
Imipramine—HRH1—endometrium—cervical cancer	0.00424	0.00713	CbGeAlD
Imipramine—CYP2E1—renal system—cervical cancer	0.00421	0.00709	CbGeAlD
Imipramine—CYP2C19—vagina—cervical cancer	0.00415	0.00699	CbGeAlD
Imipramine—HRH1—mammalian vulva—cervical cancer	0.0041	0.0069	CbGeAlD
Imipramine—KCNH2—female gonad—cervical cancer	0.00398	0.00671	CbGeAlD
Imipramine—KCNH2—vagina—cervical cancer	0.00396	0.00667	CbGeAlD
Imipramine—HTR2A—epithelium—cervical cancer	0.00395	0.00664	CbGeAlD
Imipramine—ORM1—lymph node—cervical cancer	0.0038	0.0064	CbGeAlD
Imipramine—HTR2A—renal system—cervical cancer	0.00366	0.00616	CbGeAlD
Imipramine—SLC22A4—lymph node—cervical cancer	0.00366	0.00616	CbGeAlD
Imipramine—CYP2B6—female reproductive system—cervical cancer	0.00359	0.00605	CbGeAlD
Imipramine—HRH1—female reproductive system—cervical cancer	0.00351	0.00591	CbGeAlD
Imipramine—CYP3A4—renal system—cervical cancer	0.00339	0.0057	CbGeAlD
Imipramine—CYP2E1—female reproductive system—cervical cancer	0.00337	0.00568	CbGeAlD
Imipramine—CYP2D6—renal system—cervical cancer	0.00333	0.00561	CbGeAlD
Imipramine—SLC22A3—lymph node—cervical cancer	0.00333	0.0056	CbGeAlD
Imipramine—CYP2B6—vagina—cervical cancer	0.00325	0.00547	CbGeAlD
Imipramine—HRH1—female gonad—cervical cancer	0.00319	0.00538	CbGeAlD
Imipramine—HRH1—vagina—cervical cancer	0.00317	0.00534	CbGeAlD
Imipramine—HTR2A—female reproductive system—cervical cancer	0.00293	0.00493	CbGeAlD
Imipramine—SLC6A2—lymph node—cervical cancer	0.00285	0.0048	CbGeAlD
Imipramine—CYP3A4—female reproductive system—cervical cancer	0.00271	0.00457	CbGeAlD
Imipramine—CYP2D6—female reproductive system—cervical cancer	0.00267	0.0045	CbGeAlD
Imipramine—HTR2A—vagina—cervical cancer	0.00265	0.00446	CbGeAlD
Imipramine—ABCB1—epithelium—cervical cancer	0.00259	0.00435	CbGeAlD
Imipramine—ABCB1—uterine cervix—cervical cancer	0.00256	0.00432	CbGeAlD
Imipramine—KCNH2—lymph node—cervical cancer	0.00256	0.00431	CbGeAlD
Imipramine—ABCB1—decidua—cervical cancer	0.00244	0.00411	CbGeAlD
Imipramine—CYP2D6—female gonad—cervical cancer	0.00243	0.00409	CbGeAlD
Imipramine—ABCB1—renal system—cervical cancer	0.0024	0.00404	CbGeAlD
Imipramine—ABCB1—endometrium—cervical cancer	0.00232	0.0039	CbGeAlD
Imipramine—ABCB1—mammalian vulva—cervical cancer	0.00224	0.00378	CbGeAlD
Imipramine—ABCB1—uterus—cervical cancer	0.00214	0.0036	CbGeAlD
Imipramine—HRH1—lymph node—cervical cancer	0.00205	0.00346	CbGeAlD
Imipramine—ABCB1—female reproductive system—cervical cancer	0.00192	0.00323	CbGeAlD
Imipramine—ABCB1—female gonad—cervical cancer	0.00175	0.00294	CbGeAlD
Imipramine—ABCB1—vagina—cervical cancer	0.00174	0.00292	CbGeAlD
Imipramine—ABCB1—lymph node—cervical cancer	0.00112	0.00189	CbGeAlD
Imipramine—Pancytopenia—Topotecan—cervical cancer	0.000578	0.0363	CcSEcCtD
Imipramine—Weight increased—Topotecan—cervical cancer	0.000554	0.0348	CcSEcCtD
Imipramine—Infestation—Topotecan—cervical cancer	0.000543	0.0341	CcSEcCtD
Imipramine—Infestation NOS—Topotecan—cervical cancer	0.000543	0.0341	CcSEcCtD
Imipramine—Neuropathy peripheral—Topotecan—cervical cancer	0.000532	0.0334	CcSEcCtD
Imipramine—Stomatitis—Topotecan—cervical cancer	0.000529	0.0332	CcSEcCtD
Imipramine—Hepatobiliary disease—Topotecan—cervical cancer	0.000513	0.0322	CcSEcCtD
Imipramine—Hypoaesthesia—Topotecan—cervical cancer	0.000485	0.0304	CcSEcCtD
Imipramine—Angiopathy—Topotecan—cervical cancer	0.000442	0.0277	CcSEcCtD
Imipramine—Immune system disorder—Topotecan—cervical cancer	0.00044	0.0276	CcSEcCtD
Imipramine—Mediastinal disorder—Topotecan—cervical cancer	0.000439	0.0276	CcSEcCtD
Imipramine—Alopecia—Topotecan—cervical cancer	0.00043	0.027	CcSEcCtD
Imipramine—Malnutrition—Topotecan—cervical cancer	0.000424	0.0266	CcSEcCtD
Imipramine—Ill-defined disorder—Topotecan—cervical cancer	0.000393	0.0247	CcSEcCtD
Imipramine—Malaise—Topotecan—cervical cancer	0.000382	0.024	CcSEcCtD
Imipramine—Leukopenia—Topotecan—cervical cancer	0.00038	0.0238	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.000358	0.0225	CcSEcCtD
Imipramine—Discomfort—Topotecan—cervical cancer	0.000357	0.0224	CcSEcCtD
Imipramine—Anaphylactic shock—Topotecan—cervical cancer	0.000346	0.0217	CcSEcCtD
Imipramine—Infection—Topotecan—cervical cancer	0.000344	0.0216	CcSEcCtD
Imipramine—Nervous system disorder—Topotecan—cervical cancer	0.000339	0.0213	CcSEcCtD
Imipramine—Thrombocytopenia—Topotecan—cervical cancer	0.000339	0.0213	CcSEcCtD
Imipramine—Skin disorder—Topotecan—cervical cancer	0.000336	0.0211	CcSEcCtD
Imipramine—Hyperhidrosis—Topotecan—cervical cancer	0.000335	0.021	CcSEcCtD
Imipramine—Anorexia—Topotecan—cervical cancer	0.00033	0.0207	CcSEcCtD
Imipramine—Paraesthesia—Topotecan—cervical cancer	0.000311	0.0195	CcSEcCtD
Imipramine—Dyspepsia—Topotecan—cervical cancer	0.000305	0.0191	CcSEcCtD
Imipramine—Decreased appetite—Topotecan—cervical cancer	0.000301	0.0189	CcSEcCtD
Imipramine—Gastrointestinal disorder—Topotecan—cervical cancer	0.000299	0.0188	CcSEcCtD
Imipramine—Fatigue—Topotecan—cervical cancer	0.000298	0.0187	CcSEcCtD
Imipramine—Constipation—Topotecan—cervical cancer	0.000296	0.0186	CcSEcCtD
Imipramine—Feeling abnormal—Topotecan—cervical cancer	0.000285	0.0179	CcSEcCtD
Imipramine—Gastrointestinal pain—Topotecan—cervical cancer	0.000283	0.0178	CcSEcCtD
Imipramine—Urticaria—Topotecan—cervical cancer	0.000275	0.0173	CcSEcCtD
Imipramine—Abdominal pain—Topotecan—cervical cancer	0.000274	0.0172	CcSEcCtD
Imipramine—Body temperature increased—Topotecan—cervical cancer	0.000274	0.0172	CcSEcCtD
Imipramine—Asthenia—Topotecan—cervical cancer	0.000248	0.0156	CcSEcCtD
Imipramine—Pruritus—Topotecan—cervical cancer	0.000245	0.0154	CcSEcCtD
Imipramine—Diarrhoea—Topotecan—cervical cancer	0.000237	0.0149	CcSEcCtD
Imipramine—Dizziness—Topotecan—cervical cancer	0.000229	0.0144	CcSEcCtD
Imipramine—Vomiting—Topotecan—cervical cancer	0.00022	0.0138	CcSEcCtD
Imipramine—Rash—Topotecan—cervical cancer	0.000218	0.0137	CcSEcCtD
Imipramine—Dermatitis—Topotecan—cervical cancer	0.000218	0.0137	CcSEcCtD
Imipramine—Headache—Topotecan—cervical cancer	0.000217	0.0136	CcSEcCtD
Imipramine—Nausea—Topotecan—cervical cancer	0.000206	0.0129	CcSEcCtD
Imipramine—HTR6—Signaling Pathways—WNT5A—cervical cancer	0.000156	0.000724	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—WNT5A—cervical cancer	0.000156	0.000723	CbGpPWpGaD
Imipramine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000154	0.000713	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—AKAP13—cervical cancer	0.000154	0.000712	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—WNT2—cervical cancer	0.000153	0.000707	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—WNT2—cervical cancer	0.000152	0.000703	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—CA9—cervical cancer	0.000148	0.000684	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—WNT5A—cervical cancer	0.000147	0.000683	CbGpPWpGaD
Imipramine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000147	0.000682	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—WNT2—cervical cancer	0.000145	0.000673	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—WNT5A—cervical cancer	0.000141	0.000654	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—WNT2—cervical cancer	0.000134	0.000621	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—AKAP13—cervical cancer	0.000134	0.000621	CbGpPWpGaD
Imipramine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000134	0.000619	CbGpPWpGaD
Imipramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000133	0.000618	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—AKAP13—cervical cancer	0.000133	0.000617	CbGpPWpGaD
Imipramine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000133	0.000616	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—WNT5A—cervical cancer	0.000133	0.000615	CbGpPWpGaD
Imipramine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000133	0.000614	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—WNT2—cervical cancer	0.000132	0.000611	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—WNT2—cervical cancer	0.000132	0.000609	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—WNT2—cervical cancer	0.000131	0.000607	CbGpPWpGaD
Imipramine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000131	0.000606	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—WNT2—cervical cancer	0.000131	0.000605	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—WNT2—cervical cancer	0.00013	0.0006	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—WNT2—cervical cancer	0.000129	0.000598	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—AKAP13—cervical cancer	0.000128	0.000591	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—CA9—cervical cancer	0.000127	0.000588	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—CA9—cervical cancer	0.000124	0.000576	CbGpPWpGaD
Imipramine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000121	0.000561	CbGpPWpGaD
Imipramine—DRD2—Circadian rythm related genes—TP53—cervical cancer	0.00012	0.000557	CbGpPWpGaD
Imipramine—CHRM1—Circadian rythm related genes—TP53—cervical cancer	0.000118	0.000546	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—AKAP13—cervical cancer	0.000118	0.000545	CbGpPWpGaD
Imipramine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.000117	0.00054	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—AKAP13—cervical cancer	0.000116	0.000536	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—WNT5A—cervical cancer	0.000116	0.000536	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—AKAP13—cervical cancer	0.000116	0.000535	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—AKAP13—cervical cancer	0.000115	0.000533	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—WNT5A—cervical cancer	0.000115	0.000533	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—AKAP13—cervical cancer	0.000115	0.000532	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—AKAP13—cervical cancer	0.000114	0.000526	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—AKAP13—cervical cancer	0.000113	0.000525	CbGpPWpGaD
Imipramine—SLC22A3—Metabolism—MTHFR—cervical cancer	0.000111	0.000514	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—WNT5A—cervical cancer	0.00011	0.00051	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—NOTCH2—cervical cancer	0.00011	0.000508	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—NOTCH2—cervical cancer	0.00011	0.000507	CbGpPWpGaD
Imipramine—CYP2C18—Metabolism—MTHFR—cervical cancer	0.000105	0.000486	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—NOTCH2—cervical cancer	0.000104	0.000479	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—WNT5A—cervical cancer	0.000102	0.00047	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—WNT5A—cervical cancer	0.0001	0.000463	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—WNT5A—cervical cancer	9.98e-05	0.000462	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—WNT5A—cervical cancer	9.94e-05	0.00046	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—NOTCH2—cervical cancer	9.91e-05	0.000459	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—WNT5A—cervical cancer	9.91e-05	0.000459	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—WNT5A—cervical cancer	9.82e-05	0.000454	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—WNT5A—cervical cancer	9.79e-05	0.000453	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—CA9—cervical cancer	9.6e-05	0.000445	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—CA9—cervical cancer	9.37e-05	0.000434	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—NOTCH2—cervical cancer	9.32e-05	0.000431	CbGpPWpGaD
Imipramine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	9.25e-05	0.000428	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—HES1—cervical cancer	9e-05	0.000416	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—HES1—cervical cancer	8.99e-05	0.000416	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—CA9—cervical cancer	8.83e-05	0.000409	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—HES1—cervical cancer	8.49e-05	0.000393	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—HES1—cervical cancer	8.13e-05	0.000376	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—NOTCH2—cervical cancer	8.12e-05	0.000376	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—NOTCH2—cervical cancer	8.08e-05	0.000374	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—TERT—cervical cancer	7.88e-05	0.000365	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—TERT—cervical cancer	7.87e-05	0.000365	CbGpPWpGaD
Imipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	7.76e-05	0.000359	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—NOTCH2—cervical cancer	7.73e-05	0.000358	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—HES1—cervical cancer	7.64e-05	0.000354	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CA9—cervical cancer	7.48e-05	0.000346	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—TERT—cervical cancer	7.44e-05	0.000344	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—FGFR3—cervical cancer	7.23e-05	0.000335	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—FGFR3—cervical cancer	7.23e-05	0.000335	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—NOTCH2—cervical cancer	7.13e-05	0.00033	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—TERT—cervical cancer	7.12e-05	0.00033	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—NOTCH2—cervical cancer	7.02e-05	0.000325	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—NOTCH2—cervical cancer	7e-05	0.000324	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—NOTCH2—cervical cancer	6.98e-05	0.000323	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—MTHFR—cervical cancer	6.97e-05	0.000323	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—MTHFR—cervical cancer	6.96e-05	0.000322	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—NOTCH2—cervical cancer	6.96e-05	0.000322	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—NOTCH2—cervical cancer	6.89e-05	0.000319	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—NOTCH2—cervical cancer	6.87e-05	0.000318	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—FGFR3—cervical cancer	6.82e-05	0.000316	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—NOTCH1—cervical cancer	6.79e-05	0.000314	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—NOTCH1—cervical cancer	6.78e-05	0.000314	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—TERT—cervical cancer	6.7e-05	0.00031	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—HES1—cervical cancer	6.66e-05	0.000308	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—HES1—cervical cancer	6.63e-05	0.000307	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—FGFR3—cervical cancer	6.54e-05	0.000303	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—MTHFR—cervical cancer	6.49e-05	0.0003	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—NOTCH1—cervical cancer	6.41e-05	0.000297	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—HES1—cervical cancer	6.34e-05	0.000294	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—FGFR3—cervical cancer	6.14e-05	0.000284	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—NOTCH1—cervical cancer	6.14e-05	0.000284	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—EGFR—cervical cancer	6.05e-05	0.00028	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—EGFR—cervical cancer	6.04e-05	0.00028	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—MTHFR—cervical cancer	5.99e-05	0.000277	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—HES1—cervical cancer	5.85e-05	0.000271	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—TERT—cervical cancer	5.84e-05	0.00027	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—TERT—cervical cancer	5.81e-05	0.000269	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CA9—cervical cancer	5.77e-05	0.000267	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—NOTCH1—cervical cancer	5.77e-05	0.000267	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—HES1—cervical cancer	5.75e-05	0.000266	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—HES1—cervical cancer	5.74e-05	0.000266	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—HES1—cervical cancer	5.72e-05	0.000265	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—EGFR—cervical cancer	5.71e-05	0.000264	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—HES1—cervical cancer	5.7e-05	0.000264	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—HES1—cervical cancer	5.65e-05	0.000261	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—HES1—cervical cancer	5.63e-05	0.000261	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—TERT—cervical cancer	5.56e-05	0.000257	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—EGFR—cervical cancer	5.47e-05	0.000253	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—FGFR3—cervical cancer	5.35e-05	0.000248	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—FGFR3—cervical cancer	5.33e-05	0.000247	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—MTHFR—cervical cancer	5.16e-05	0.000239	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—EGFR—cervical cancer	5.14e-05	0.000238	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TERT—cervical cancer	5.12e-05	0.000237	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—FGFR3—cervical cancer	5.1e-05	0.000236	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—MTOR—cervical cancer	5.09e-05	0.000236	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—MTOR—cervical cancer	5.08e-05	0.000235	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—MTHFR—cervical cancer	5.05e-05	0.000234	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TERT—cervical cancer	5.04e-05	0.000233	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TERT—cervical cancer	5.03e-05	0.000233	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—NOTCH1—cervical cancer	5.03e-05	0.000233	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TERT—cervical cancer	5.01e-05	0.000232	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—NOTCH1—cervical cancer	5e-05	0.000232	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TERT—cervical cancer	5e-05	0.000231	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TERT—cervical cancer	4.95e-05	0.000229	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TERT—cervical cancer	4.94e-05	0.000228	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—MTOR—cervical cancer	4.8e-05	0.000222	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—NOTCH1—cervical cancer	4.79e-05	0.000222	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—FGFR3—cervical cancer	4.7e-05	0.000218	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—CASP3—cervical cancer	4.68e-05	0.000217	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—CASP3—cervical cancer	4.68e-05	0.000216	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—FGFR3—cervical cancer	4.63e-05	0.000214	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—FGFR3—cervical cancer	4.62e-05	0.000214	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—FGFR3—cervical cancer	4.6e-05	0.000213	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—MTOR—cervical cancer	4.6e-05	0.000213	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—FGFR3—cervical cancer	4.59e-05	0.000212	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—FGFR3—cervical cancer	4.54e-05	0.00021	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—FGFR3—cervical cancer	4.53e-05	0.00021	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—CTNNB1—cervical cancer	4.51e-05	0.000209	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—CTNNB1—cervical cancer	4.51e-05	0.000209	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—EGFR—cervical cancer	4.48e-05	0.000207	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—EGFR—cervical cancer	4.46e-05	0.000206	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—CASP3—cervical cancer	4.42e-05	0.000204	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—NOTCH1—cervical cancer	4.41e-05	0.000204	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—NOTCH1—cervical cancer	4.34e-05	0.000201	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—NOTCH1—cervical cancer	4.33e-05	0.000201	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—MTOR—cervical cancer	4.32e-05	0.0002	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—NOTCH1—cervical cancer	4.32e-05	0.0002	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—NOTCH1—cervical cancer	4.31e-05	0.000199	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—EGFR—cervical cancer	4.27e-05	0.000197	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—NOTCH1—cervical cancer	4.26e-05	0.000197	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—CTNNB1—cervical cancer	4.26e-05	0.000197	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—NOTCH1—cervical cancer	4.25e-05	0.000197	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—CASP3—cervical cancer	4.23e-05	0.000196	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—CTNNB1—cervical cancer	4.08e-05	0.000189	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—CASP3—cervical cancer	3.98e-05	0.000184	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—STAT3—cervical cancer	3.93e-05	0.000182	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—EGFR—cervical cancer	3.93e-05	0.000182	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—STAT3—cervical cancer	3.93e-05	0.000182	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—MTHFR—cervical cancer	3.9e-05	0.00018	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—EGFR—cervical cancer	3.87e-05	0.000179	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—EGFR—cervical cancer	3.86e-05	0.000179	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—EGFR—cervical cancer	3.85e-05	0.000178	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—EGFR—cervical cancer	3.84e-05	0.000178	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—CTNNB1—cervical cancer	3.83e-05	0.000177	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—MTHFR—cervical cancer	3.8e-05	0.000176	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—EGFR—cervical cancer	3.8e-05	0.000176	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—EGFR—cervical cancer	3.79e-05	0.000175	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—MTOR—cervical cancer	3.77e-05	0.000174	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—MTOR—cervical cancer	3.75e-05	0.000173	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—STAT3—cervical cancer	3.71e-05	0.000172	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—MTOR—cervical cancer	3.59e-05	0.000166	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—MTHFR—cervical cancer	3.58e-05	0.000166	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—EGFR—cervical cancer	3.57e-05	0.000165	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—EGFR—cervical cancer	3.57e-05	0.000165	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—STAT3—cervical cancer	3.55e-05	0.000164	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CASP3—cervical cancer	3.46e-05	0.00016	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CASP3—cervical cancer	3.45e-05	0.00016	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—EGFR—cervical cancer	3.37e-05	0.000156	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—STAT3—cervical cancer	3.34e-05	0.000155	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CTNNB1—cervical cancer	3.34e-05	0.000155	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CTNNB1—cervical cancer	3.32e-05	0.000154	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—MTOR—cervical cancer	3.31e-05	0.000153	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CASP3—cervical cancer	3.3e-05	0.000153	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—MTOR—cervical cancer	3.25e-05	0.000151	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—MTOR—cervical cancer	3.25e-05	0.00015	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—MTOR—cervical cancer	3.24e-05	0.00015	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—EGFR—cervical cancer	3.23e-05	0.000149	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—MTOR—cervical cancer	3.23e-05	0.000149	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—MTOR—cervical cancer	3.2e-05	0.000148	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—MTOR—cervical cancer	3.19e-05	0.000148	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CTNNB1—cervical cancer	3.18e-05	0.000147	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CASP3—cervical cancer	3.04e-05	0.000141	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—MTHFR—cervical cancer	3.04e-05	0.000141	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—EGFR—cervical cancer	3.04e-05	0.000141	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—TP53—cervical cancer	3e-05	0.000139	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—TP53—cervical cancer	3e-05	0.000139	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CASP3—cervical cancer	2.99e-05	0.000139	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CASP3—cervical cancer	2.99e-05	0.000138	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CASP3—cervical cancer	2.98e-05	0.000138	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CASP3—cervical cancer	2.97e-05	0.000137	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CASP3—cervical cancer	2.94e-05	0.000136	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CTNNB1—cervical cancer	2.93e-05	0.000136	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CASP3—cervical cancer	2.93e-05	0.000136	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—STAT3—cervical cancer	2.91e-05	0.000135	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—STAT3—cervical cancer	2.9e-05	0.000134	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CTNNB1—cervical cancer	2.89e-05	0.000134	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CTNNB1—cervical cancer	2.88e-05	0.000133	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CTNNB1—cervical cancer	2.87e-05	0.000133	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CTNNB1—cervical cancer	2.86e-05	0.000132	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CTNNB1—cervical cancer	2.83e-05	0.000131	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—TP53—cervical cancer	2.83e-05	0.000131	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CTNNB1—cervical cancer	2.83e-05	0.000131	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—STAT3—cervical cancer	2.77e-05	0.000128	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—TP53—cervical cancer	2.71e-05	0.000126	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—EGFR—cervical cancer	2.65e-05	0.000122	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—EGFR—cervical cancer	2.63e-05	0.000122	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—STAT3—cervical cancer	2.56e-05	0.000118	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—TP53—cervical cancer	2.55e-05	0.000118	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—EGFR—cervical cancer	2.52e-05	0.000117	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—STAT3—cervical cancer	2.52e-05	0.000116	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—STAT3—cervical cancer	2.51e-05	0.000116	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—STAT3—cervical cancer	2.5e-05	0.000116	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—STAT3—cervical cancer	2.49e-05	0.000115	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—STAT3—cervical cancer	2.47e-05	0.000114	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—STAT3—cervical cancer	2.46e-05	0.000114	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—MTHFR—cervical cancer	2.34e-05	0.000108	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—EGFR—cervical cancer	2.32e-05	0.000108	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—EGFR—cervical cancer	2.29e-05	0.000106	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—EGFR—cervical cancer	2.28e-05	0.000106	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—EGFR—cervical cancer	2.27e-05	0.000105	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—EGFR—cervical cancer	2.27e-05	0.000105	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—EGFR—cervical cancer	2.24e-05	0.000104	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—EGFR—cervical cancer	2.24e-05	0.000104	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—TP53—cervical cancer	2.22e-05	0.000103	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—TP53—cervical cancer	2.21e-05	0.000102	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—TP53—cervical cancer	2.12e-05	9.79e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TP53—cervical cancer	1.95e-05	9.03e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TP53—cervical cancer	1.92e-05	8.88e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TP53—cervical cancer	1.92e-05	8.87e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TP53—cervical cancer	1.91e-05	8.84e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TP53—cervical cancer	1.9e-05	8.81e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TP53—cervical cancer	1.88e-05	8.72e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TP53—cervical cancer	1.88e-05	8.7e-05	CbGpPWpGaD
